Auraptene ameliorates osteoporosis by inhibiting RANKL/NFATc1 pathway-mediated bone resorption based on network pharmacology and experimental evaluation.

Name: Auraptene ameliorates osteoporosis by inhibiting RANKL/NFATc1 pathway-mediated bone resorption based on network pharmacology and experimental evaluation.
Author: Kim, Mi H

Auraptene ameliorates osteoporosis by inhibiting RANKL/NFATc1 pathway-mediated bone resorption based on network pharmacology and experimental evaluation. — المؤلف: Kim, Mi H — Bone & joint research May 2022

المؤلف: Kim, Mi H
النشر: Bone & joint research May 2022
الوصف: 304-316 p.